NCT02809027

Brief Summary

The purpose of this study is to determine ginger is effective in the prevention of abdominal distention in post Cesarean section patient.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
178

participants targeted

Target at P50-P75 for phase_4

Timeline
Completed

Started Jun 2016

Shorter than P25 for phase_4

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2016

Completed
15 days until next milestone

First Submitted

Initial submission to the registry

June 16, 2016

Completed
6 days until next milestone

First Posted

Study publicly available on registry

June 22, 2016

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2017

Completed
Last Updated

July 15, 2020

Status Verified

July 1, 2020

Enrollment Period

1.1 years

First QC Date

June 16, 2016

Last Update Submit

July 14, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • incidence abdominal distention as measured by diary chart (history taking and examination)

    72 hours

Secondary Outcomes (6)

  • Maternal satisfaction as measured by questionaire

    72 hours

  • Quality of life as measured by questionaire

    72 hours

  • nausea vomiting as measured by questionaire

    72 hours

  • first time to pass flatus/feces as measured by diary chart

    72 hours

  • number of carminative drug use as measured by questionaire

    72 hours

  • +1 more secondary outcomes

Study Arms (2)

Ginger

ACTIVE COMPARATOR

Ginger capsule (500 mg), oral form, 2 capsules 3 time after meal for 3 days

Drug: Ginger

Placebo

SHAM COMPARATOR

Placebo capsule, oral form, 2 capsules 3 time after meal for 3 days

Drug: Placebo

Interventions

GingerDRUG
Ginger
Placebo

Eligibility Criteria

Age18 Years - 40 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Post cesarean section women

You may not qualify if:

  • allergic to ginger
  • time of cesarean section more than 1 hour
  • perform another operation such as appendectomy, cystectomy
  • former use carminative drugs
  • already have abdominal distention

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (6)

  • Carroll J, Alavi K. Pathogenesis and management of postoperative ileus. Clin Colon Rectal Surg. 2009 Feb;22(1):47-50. doi: 10.1055/s-0029-1202886.

    PMID: 20119556BACKGROUND
  • Chaiyakunapruk N, Kitikannakorn N, Nathisuwan S, Leeprakobboon K, Leelasettagool C. The efficacy of ginger for the prevention of postoperative nausea and vomiting: a meta-analysis. Am J Obstet Gynecol. 2006 Jan;194(1):95-9. doi: 10.1016/j.ajog.2005.06.046.

    PMID: 16389016BACKGROUND
  • O'Hara M, Kiefer D, Farrell K, Kemper K. A review of 12 commonly used medicinal herbs. Arch Fam Med. 1998 Nov-Dec;7(6):523-36. doi: 10.1001/archfami.7.6.523.

    PMID: 9821826BACKGROUND
  • Ushiroyama T, Sakuma K, Souen H, Nakai G, Morishima S, Yamashita Y, Kamegai H. Xiong-gui-tiao-xue-yin (Kyuki-chouketsu-in), a traditional herbal medicine, stimulates lactation with increase in secretion of prolactin but not oxytocin in the postpartum period. Am J Chin Med. 2007;35(2):195-202. doi: 10.1142/S0192415X07004734.

    PMID: 17436360BACKGROUND
  • Gibstein A, Cooper JJ, Wisot AL, Rosenthal AH. Prevention of postoperative abdominal distention and discomfort with simethicone. Obstet Gynecol. 1971 Sep;38(3):386-90. No abstract available.

  • Hu ML, Rayner CK, Wu KL, Chuah SK, Tai WC, Chou YP, Chiu YC, Chiu KW, Hu TH. Effect of ginger on gastric motility and symptoms of functional dyspepsia. World J Gastroenterol. 2011 Jan 7;17(1):105-10. doi: 10.3748/wjg.v17.i1.105.

MeSH Terms

Interventions

ginger extract

Study Officials

  • Vorapong Phupong, M.D.

    Chulalongkorn University

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor Vorapong Phupong

Study Record Dates

First Submitted

June 16, 2016

First Posted

June 22, 2016

Study Start

June 1, 2016

Primary Completion

June 30, 2017

Study Completion

June 30, 2017

Last Updated

July 15, 2020

Record last verified: 2020-07